DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Deciphera Pharmaceuticals LLC (DCPH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $25.00M | $42.09M | $96.15M | $134.04M | $163.36M |
| Revenue growth (YoY) | — | — | — | — | — | +68.3% | +128.5% | +39.4% | +21.9% |
| Cost of revenue | $0.00 | $0.00 | $0.00 | $0.00 | $830000.00 | $225000.00 | $2.93M | $8.77M | $3.73M |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $24.17M | $41.86M | $93.22M | $125.27M | $159.62M |
| Gross margin | — | — | — | — | 96.7% | 99.5% | 97.0% | 93.5% | 97.7% |
| R&D | $12.47M | $20.16M | $39.51M | $82.89M | $157.61M | $198.97M | $257.04M | $187.82M | $234.12M |
| SG&A | $5.13M | $5.67M | $11.42M | $21.21M | $68.12M | $114.08M | $136.25M | $120.17M | $129.51M |
| Operating income | $-17.61M | $-25.84M | $-50.94M | $-104.10M | $-200.73M | $-271.19M | $-300.08M | $-182.72M | $-210.96M |
| Operating margin | — | — | — | — | -802.9% | -644.4% | -312.1% | -136.3% | -129.1% |
| EBITDA | $-17.53M | $-25.74M | $-50.04M | $-99.77M | $-192.19M | $-264.18M | $-297.06M | $-179.78M | $-210.96M |
| EBITDA margin | — | — | — | — | -768.8% | -627.7% | -309.0% | -134.1% | -129.1% |
| EBIT | $-17.61M | $-25.83M | $-50.19M | $-100.09M | $-200.73M | $-271.19M | $-300.08M | $-182.72M | $-210.96M |
| Interest expense | $2.21M | $106000.00 | $95000.00 | $84000.00 | $67000.00 | $4.70M | $113000.00 | $4.51M | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-19.82M | $-25.94M | $-50.28M | $-99.85M | $-191.49M | $-266.49M | $-296.84M | $-178.93M | $-194.94M |
| Net income growth (YoY) | — | -30.9% | -93.8% | -98.6% | -91.8% | -39.2% | -11.4% | +39.7% | -8.9% |
| Profit margin | — | — | — | — | -766.0% | -633.2% | -308.7% | -133.5% | -119.3% |